Coca-Cola Europacific Partners PLC (CCEP) AI Stock Analysis
CCEP AI stock analysis summary
AI ResearchCoca-Cola Europacific Partners PLC produces and sells non-alcoholic ready-to-drink beverages globally. Over the trailing twelve months, the company generated $21.35B in revenue with an operating margin of 13.4%. Net debt stands at $10.19B as of June 30, 2026.
- Market cap
- $49.39B
- Revenue (TTM)
- $21.35B
- P/E
- 21.7x fwd 18.2x
- 1Y return
- 29.3% S&P 500 16.8%
- Avg. target
- $109.29 -2.8% vs last close
Bull case
- Trailing twelve months return on equity reached 23.5%, supported by an operating margin of 13.4%.
- Free cash flow generation remained steady at $2.20B in FY2025, supporting $1.00B in share repurchases and $890.4M in dividends.
- The forward P/E of 18.2x sits at a discount to the median of its Nasdaq-100 Consumer Defensive peers of 25.9x.
Bear case
- Total debt of $12.18B results in net debt of $10.19B and a debt-to-equity ratio of 1.47 as of June 30, 2026.
- The current ratio is 0.89, indicating short-term obligations exceed liquid assets.
- The mean price target of $109.29 implies the stock trades 2.8% above consensus expectations.
What Coca-Cola Europacific does
Coca-Cola Europacific Partners PLC, alongside its subsidiaries, is a player in the non-alcoholic ready-to-drink beverage industry, specializing in production, distribution, and sales. The company offers a portfolio including soft drinks, waters, enhanced waters, isotonic drinks, and energy drinks under brands such as Coca-Cola, Diet Coke, Fanta, Sprite, Monster Energy, and Coca-Cola Energy. It also provides ready-to-drink tea, coffee, and juices under brands including Appletiser, Schweppes, Honest, Costa Coffee, and Tropico. Leveraging its distribution network, the company serves approximately 600 million consumers globally from its headquarters in Uxbridge, the United Kingdom.
Growth and profitability
Revenue increased from $13.76B in FY2021 to $17.32B in FY2022, $18.30B in FY2023, $20.44B in FY2024, and $20.90B in FY2025. Over the 5 years from FY2020 to FY2025, revenue grew at a CAGR of 14.5%. Gross margin was 37.1% in FY2021 and 35.6% in FY2025, while operating margin rose from 11.0% in FY2021 to 13.4% in FY2025. Annual net income increased from $982.0M in FY2021 to $1.94B in FY2025. For the trailing twelve months ended June 30, 2026, revenue was $21.35B, with quarterly revenue growth of 4.4% and quarterly earnings growth of 9.0%.
Balance sheet and cash flow
As of June 30, 2026, cash and short-term investments totaled $1.99B, total debt stood at $12.18B, and net debt was $10.19B. Total assets were $32.47B against shareholders' equity of $8.27B. The current ratio stood at 0.89 and debt-to-equity was 1.47. In FY2025, operating cash flow reached $2.95B and free cash flow was $2.20B. Cash deployment in FY2025 included $750.0M for capital expenditures, $890.4M for dividends, and $1.00B for share buybacks.
Valuation and performance
CCEP closed at $112.40 on October 16, 2026, with a market cap of $49.39B and enterprise value of $56.21B. The stock trades at a trailing P/E of 21.7x and a forward P/E of 18.2x, below the median of its Nasdaq-100 Consumer Defensive peers of 38.7x and 25.9x. Its EV-to-EBITDA is 12.8x compared to the peer median of 18.4x, while price-to-sales is 2.3x compared to 1.9x for peers. Over the past 1 year, CCEP gained 29.3% versus 16.8% for SPY, and over 5 years returned 139.6% versus 83.0% for SPY.
CCEP dividend
CCEP pays a semiannual dividend with an annualized forward payout of $2.41 per share, representing a dividend yield of 2.14%. The payout ratio is 46.6%. The company has paid dividends for 40 consecutive years, achieving a 5-year annualized dividend growth rate of 18.5%. The last ex-dividend date was May 15, 2026.
What analysts expect
Wall Street coverage includes 7 Strong Buy, 1 Buy, 4 Hold, 1 Sell, and 0 Strong Sell recommendations. The mean price target is $109.29, which sits 2.8% below the last close of $112.40. For the fiscal year ending December 31, 2026, analysts estimate EPS of $4.50 on revenue of $21.63B. For the following fiscal year, 11 analysts project EPS of $4.92 and revenue of $22.48B. CCEP has beaten EPS estimates in 1 of the last 4 quarters.
Key risks and what to watch
- A current ratio of 0.89 poses liquidity risks if operating cash generation declines.
- CCEP carries net debt of $10.19B against shareholders' equity of $8.27B.
- The company has exceeded consensus EPS projections in only 1 of the trailing 4 quarters.
- Revenue growth moderated to 2.3% in FY2025 compared to 11.7% in FY2024.
AI-generated research summary. Written with AI from Quotelinks data as of October 16, 2026 and checked so every figure matches that data. For information only, not investment advice. Disclaimer
About this CCEP AI stock analysis
This page is an AI-written research summary of Coca-Cola Europacific Partners PLC (CCEP). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.
Related: CCEP income statement, CCEP balance sheet, CCEP key metrics, CCEP analyst forecast, CCEP chart. See the CCEP stock overview for the latest quote and news.
CCEP AI stock analysis FAQ
What is CCEP's current dividend yield?
CCEP offers an indicated dividend yield of 2.14% based on an annual forward payout of $2.41. Dividends are distributed on a semiannual schedule.
How does CCEP's valuation compare to sector peers?
CCEP trades at a trailing P/E of 21.7x and an EV-to-EBITDA of 12.8x. Both multiples trade below the median of its Nasdaq-100 Consumer Defensive peers, which stand at 38.7x and 18.4x.
What is CCEP's debt position?
As of June 30, 2026, CCEP holds $1.99B in cash and short-term investments against $12.18B in total debt, yielding net debt of $10.19B. Its debt-to-equity ratio is 1.47.
What are analysts forecasting for CCEP's earnings?
For the fiscal year ending December 31, 2026, analysts estimate EPS of $4.50. For the following fiscal year, 11 analysts project EPS of $4.92, representing expected growth of 9.2%.